Neurocrine Biosciences
(NASDAQ) NBIX
Neurocrine Biosciences Financials at a Glance
Market Cap
$16.04B
Revenue (TTM)
$3.10B
Net Income (TTM)
$668.60M
EPS (TTM)
$6.50
P/E Ratio
24.52
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$159.51
Volume
1,243,782.597
Open
$159.89
Price
$159.51
Volume
1,243,782.597
Open
$159.89
Previous Close
$159.51
Daily Range
$156.70 - $160.55
52-Week Range
$122.14 - $169.57
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.62 (Low)
Price
$159.51
Volume
1,243,782.597
Open
$159.89
Previous Close
$159.51
Daily Range
$156.70 - $160.55
52-Week Range
$122.14 - $169.57
Estimated Earnings Date
Jul 29, 2026
NBIX News
NBIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Neurocrine Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
2,000
CEO
Kyle W. Gano, PhD, MBA
Website
www.neurocrine.comHeadquarters
San Diego, CA 92130, US
NBIX Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
25%
Net Income Margin
22%
Return on Equity
23%
Return on Capital
19%
Return on Assets
14%
Earnings Yield
4.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.04B
Shares Outstanding
100.55M
Volume
1.24M
Avg. Volume
1.17M
Financials (TTM)
Gross Profit
$2.81B
Operating Income
$619.10M
EBITDA
$666.60M
Operating Cash Flow
$782.70M
Capital Expenditure
-$34.00M
Free Cash Flow
$748.70M
Cash & ST Invst.
$1.48B
Total Debt
$415.30M
Neurocrine Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$814.50M
+42.2%
Gross Profit
$800.70M
+42.1%
Gross Margin
98.31%
N/A
Market Cap
$16.04B
N/A
Market Cap/Employee
$8.91M
N/A
Employees
1,800
N/A
Net Income
$197.90M
+2405.1%
EBITDA
$254.10M
+711.8%
Quarterly Fundamentals
Total Cash
$1.32B
+39.5%
Total Debt
$406.20M
-9.2%
Accounts Receivable
$768.10M
+48.9%
Inventory
$64.50M
+9.1%
Long Term Debt
$406.20M
-9.2%
Short Term Debt
$0.00
N/A
Return on Assets
13.63%
N/A
Return on Invested Capital
19.18%
N/A
Free Cash Flow
$136.70M
+152.7%
Operating Cash Flow
$145.80M
+125.0%